|
Virotherapy for Neuroblastoma Stem Cells
|
1R21CA133663-01A1
|
$168,750
|
|
CRIPE, TIMOTHY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Viral Vaccine Vectors to Prevent Hepatocellular Carcinoma
|
1R01CA131133-01A1
|
$274,730
|
|
ROBEK, MICHAEL
|
YALE UNIVERSITY
|
|
VEGF-based Targeted Imaging of Tumor Vasculature
|
5R44CA113080-03
|
$564,762
|
|
Backer, Joseph
|
SIBTECH, INC.
|
|
Variations in Colonoscopy Screening: A Population Based Study
|
1R01CA131141-01A1
|
$661,835
|
|
Dietrich, Allen
|
DARTMOUTH COLLEGE
|
|
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers
|
1R01CA129226-01A1
|
$461,848
|
|
STEIN, MICHAEL
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS
|
2R42CA122715-03
|
$748,362
|
|
SAXENA, SATYA
|
CALIBRANT BIOSYSTEMS, INC.
|
|
Using Mouse Endoscopy for Evaluating Colon Cancer
|
1R01CA125691-01A2
|
$354,513
|
|
Rosenberg, Daniel
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Using Email to Enhance Counseling Services at NCI's Smoking Cessation Quitline
|
1K07CA124579-01A2
|
$134,580
|
|
ABROMS, LORIEN
|
GEORGE WASHINGTON UNIVERSITY
|
|
Use of Serum HPV16 DNA as a Marker for Oropharyngeal Cancer Recurrence
|
5R03CA128110-02
|
$77,000
|
|
STURGIS, ERICH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Use of Beta-lapachone for Lung Cancer Chemotherapy
|
2R01CA102792-06
|
$341,159
|
|
Boothman, David
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
Underutilization of Surgical Resection in Patients with Pancreatic Cancer
|
1K07CA130983-01A1
|
$126,591
|
|
RIALL, TAYLOR
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Ultra-Sensitive MR Probes for Molecular Diagnosis of Lung Cancer
|
1R01CA129011-01A1
|
$325,775
|
|
GAO, JINMING
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
Tumor Cell Biology Training Program
|
5T32CA009361-28
|
$345,047
|
|
STILES, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
True 3D Display for IGRI
|
1R43CA138566-01
|
$150,000
|
|
Geng, Jason
|
XIGEN, LLC
|
|
Translational linkage strategies for DNA vaccines against cancer
|
5F31CA130744-02
|
$40,972
|
|
Alonzo, Eric
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Transgenic in vivo delivery of MDA7/IL24 for maligannt glioma therapy
|
1R01CA129489-01A2
|
$342,194
|
|
GERMANO, ISABELLE
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Transformation of Cells by the REL Oncogene
|
3R01CA047763-20S1
|
$10,000
|
|
GILMORE, THOMAS
|
BOSTON UNIVERSITY
|
|
Transcription Factor Reporter Technology
|
1R33CA134385-01
|
$323,913
|
|
Bogdanov, Alexei
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Training in Radiation Oncology
|
5T32CA061801-13
|
$186,145
|
|
LING, CLIFTON
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
TRAINING GRANT IN VIRAL AND CHEMICAL CARCINOGENESIS
|
2T32CA009320-24
|
$241,247
|
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Therapeutic Application of Novel Stat3 Inhibitors in Breast and Pancreatic Cancer
|
1R01CA128865-01A1
|
$188,029
|
|
TURKSON, JAMES
|
UNIVERSITY OF CENTRAL FLORIDA
|
|
The therapeutic potential of maspin in prostate cancer
|
2R01CA084176-06A2
|
$261,975
|
|
SHENG, SHIJIE
|
WAYNE STATE UNIVERSITY
|
|
The Self Regulation Model in BRCA 1/2 Genetic Counseling
|
1R03CA128459-01A2
|
$75,000
|
|
Kelly, Kimberly
|
OHIO STATE UNIVERSITY
|
|
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
|
1K08CA134649-01
|
$127,170
|
|
LI, QING
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
The role of FOXO transcriptional factors in TSC-mediated tumorigenesis
|
1R21CA135057-01
|
$171,000
|
|
DePinho, Ronald
|
DANA-FARBER CANCER INSTITUTE
|
|
The Odd-Even Effect of Polymorphic CA repeats in the 5' Regulatory Region of the
|
5R03CA128025-02
|
$77,000
|
|
GORLOV, IVAN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The NF-kB Target, Gadd45Beta, in Lymphocytes and Liver
|
7R01CA084040-09
|
$217,607
|
|
FRANZOSO, GUIDO
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
The Influence of HIV Disease Events/Stages on Smoking Attitudes and Behaviors
|
1R01CA132636-01A1
|
$319,550
|
|
Vidrine, Damon
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Hedgehog Pathway and Lung Cancer Prevention
|
5R03CA132166-02
|
$79,950
|
|
DMITROVSKY, ETHAN
|
DARTMOUTH COLLEGE
|
|
The Familial Colorectal Neoplasia Collaborative Group
|
2U24CA074800-10
|
$1,153,640
|
|
LINDOR, NORALANE
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
THE EFFECT OF LYCOPENE ON IGF-1 ACTIVITY AND SECRETION IN PRIMARY CULTURES OF PRO
|
5R03CA131595-02
|
$78,500
|
|
NONN, LARISA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
The effect of antismoking parenting practices on adolescent smoking
|
1R03CA132549-01A1
|
$78,750
|
|
RODRIGUEZ, DANIEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Development of Vitamin D as a Therapy for Breast Cancer
|
1R01CA130991-01A1
|
$295,065
|
|
Feldman, David
|
STANFORD UNIVERSITY
|
|
The Development of a Health Numeracy Measure
|
5R01CA115954-02
|
$408,218
|
|
SCHAPIRA, MARILYN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
The Colon Cancer Family Registry: USC Consortium
|
2U24CA074799-10
|
$1,923,580
|
|
HAILE, ROBERT
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
The Colon Cancer Family Registry: Seattle
|
2U24CA074794-11
|
$1,716,570
|
|
NEWCOMB, POLLY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Colon Cancer Family Registry: Ontario
|
2U24CA074783-10
|
$1,014,593
|
|
GALLINGER, STEVEN
|
CANCER CARE ONTARIO
|
|
The Colon Cancer Family Registry: Hawaii
|
2U24CA074806-10
|
$408,946
|
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
The Colon Cancer Family Registry: Australasia
|
2U24CA097735-06
|
$1,484,815
|
|
HOPPER, JOHN
|
UNIVERSITY OF MELBOURNE
|
|
TGF beta Receptor and Tumor Progression
|
2R01CA079683-09A1
|
$221,020
|
|
SUN, LUZHE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Testing Alternative Stage Models of Smoking Cessation: An Intervention Study
|
5R01CA120799-02
|
$193,040
|
|
HERZOG, THADDEUS
|
WEST VIRGINIA UNIVERSITY
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$131
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Targeting Retroviral DNA Integration: Role of Host Cell Proteins
|
1R21CA135214-01
|
$208,575
|
|
DANIEL, RENE
|
THOMAS JEFFERSON UNIVERSITY
|
|
Targeting p53 for colon cancer treatment & prevention
|
1R21CA125592-01A2
|
$216,892
|
|
GIARDINA, CHARLES
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
TARGETING FLIP FOR PROSTATE CANCER PREVENTION
|
1R01CA135451-01
|
$303,116
|
|
KUMAR, ADDANKI
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Targeting Egr-1 with Curcumin Analogs for Prostate Cancer Prevention
|
1R03CA136030-01
|
$75,000
|
|
BISOFFI, MARCO
|
UNIVERSITY OF NEW MEXICO
|
|
Targeting cell trafficking as a new therapeutic modality for Multiple Myeloma
|
1R01CA133799-01A1
|
$352,995
|
|
Ghobrial, Irene
|
DANA-FARBER CANCER INSTITUTE
|
|
Targeted Lipopolyplexes for Oligonucleotide Delivery to AML
|
1R01CA135243-01
|
$463,154
|
|
Lee, Robert
|
OHIO STATE UNIVERSITY
|
|
TARGET-GUIDED DEVELOPMENT OF SPECIFIC AKT INHIBITORS
|
5R01CA115521-04
|
$423,289
|
|
VOGT, PETER
|
SCRIPPS RESEARCH INSTITUTE
|
|
Tailored Interactive Multimedia to Reduce Colorectal CA Screening Disparities
|
1R01CA131386-01A1
|
$498,024
|
|
JERANT, ANTHONY
|
UNIVERSITY OF CALIFORNIA DAVIS
|
Total relevant funding to Herpes - Genital for this search: $923,346
|